FindTrial
Sign In

A comparative study of effectiveness of Alpha2 agonist (Dexmedetomidine) versus opioid (fentanyl) for awake intubation using flexible bronchoscope

A comparative study of safety and effectiveness of Dexmedetomidine versus Fentanyl for awake fiberoptic intubation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/041196
Enrollment
60
Registered
2022-03-17
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Fentanyl 1ug/kg intavenous infusion: Fentanyl 1ug/kg intavenous infusion given over 10-15minutes Control Intervention1: Dexmedetomidine 1ug/kd intravenous infusion: Dexmedetomidine 1ug/

Sponsors

Vinayaka missions kirupanda variyar medical college and hospital
Lead Sponsor
DR Sabapathy
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: ASA-PS grading 1,2 Mallampati grading 1,2

Exclusion criteria

Exclusion criteria: Patient unwilling for the procedure Age 50 years History of bleeding disorder History of unstable angina Resting heart rate MP 3,4

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of Dexmedetomidine(1ug/kg)and Fentanyl (1ug/kg) for sedation and patients comfort and compliance during awake fiberoptic intubationTimepoint: Ramsay Sedation score, Cough Score, Post Intubation Score, BP, Heart Rate, Spo2 for 15 minutes intraoperatively—

Secondary

MeasureTime frame
To monitor complications like respiratory depression, fall in SPO2, bradycardia, hypotensionTimepoint: baseline, after giving study drugs, post intubation—

Countries

India

Contacts

Public ContactSagana Sekar

Vinayaka Mission Kirupanada Variyar Medical College and Hospital

sabapathyva@yahoo.com09489427563

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026